Sanofi slashes price of wannabe-blockbuster cholesterol drug
Sales of Praluent have been hurt by the campaign to limit US pharmaceuticals costs
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Cholesterol | Pharmaceuticals